Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Breast Neoplasms 15Vitamin D Deficiency 13Prostatic Neoplasms 13Polycystic Ovary Syndrome 8Neoplasms 7Osteoporosis 4Colorectal Neoplasms 4Warts 3Rectal Neoplasms 3Ovarian Neoplasms 3Myelodysplastic Syndromes 3Leukemia, Lymphocytic, Chronic, B-Cell 3Colonic Neoplasms 3Brain Neoplasms 3Male Urogenital Diseases 2Leukemia 2Cardiovascular Diseases 2Adenomatous Polyps 2Stroke 1Spinal Cord Injuries 1Skin Neoplasms 1Seizures 1Psoriasis 1Prostate Adenocarcinoma 1Premature Birth 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyps 1Pathologic Processes 1Pain 1Osteoarthritis 1

Interventions

fludarabine phosphate 58Cyclophosphamide 54Peripheral Blood Stem Cell Transplantation 49Mycophenolic Acid 39Busulfan 38Tacrolimus 37Cyclosporine 33Antilymphocyte Serum 33Whole-Body Irradiation 32Filgrastim 28Methotrexate 27Radiotherapy 20Melphalan 18Cytarabine 17fludarabine 16Etoposide 16Methylprednisolone 14ruxolitinib 11sargramostim 9Flow Cytometry 9Cyclosporins 9Cord Blood Stem Cell Transplantation 9Alemtuzumab 9thymoglobulin 8Sirolimus 8Psychiatric Rehabilitation 8Granulocyte Colony-Stimulating Factor 8Azacitidine 8merphos 7Decitabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Myeloproliferative Disorders × Cholecalciferol × Clear all
NCT00068276 2018-08-10

Cholecalciferol in Treating Patients With Myelodysplastic Syndrome

Wake Forest University Health Sciences

Phase 2 Completed
MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡